MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.59
-0.74 (-4.27%)
At close: Aug 11, 2026, 4:00 PM EDT
16.59
0.00 (0.00%)
Pre-market: Aug 12, 2026, 4:28 AM EDT
MLTX Market Cap
MLTX has a market cap or net worth of $1.41 billion as of August 11, 2026. Its market cap has decreased by -57.57% in one year.
Market Cap
1.41B
Enterprise Value
976.42M
1-Year Change
-57.57%
Ranking
Category
Stock Price
$16.59
ChartMarket Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $1.41B, an increase of 39,140.94%. That is a compound annual growth rate of 278.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 1.41B | 50.09% |
| Dec 31, 2025 | 940.70M | -72.45% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
| Feb 14, 2022 | 3.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.50B |
| ArriVent BioPharma | 1.46B |
| Obsidian Therapeutics | 1.43B |
| ORIC Pharmaceuticals | 1.42B |
| Jade Biosciences | 1.42B |
| Savara | 1.41B |
| Vor Biopharma | 1.40B |
| Aktis Oncology | 1.37B |